Global Pharma Bidders May Queue Up For A Slice Of Mankind Pharma And Scorching 25 Percent Growth

MUMBAI - India's Mankind Pharma, which has seen exponential year-on-year growth of more than 25 percent, may be the latest attraction for large multinational pharma companies as speculation gathers steam that its deep roots in the largely untapped semi-urban and rural markets makes it an enviable takeover target

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip